Is IQWiG's 15% threshold universally applicable in assessing the clinical relevance of patient reported outcomes changes? An ISPOR Special Interest Group report.

8 September 2022 - To assess the clinical relevance of patient reported outcomes, a response threshold of ≥ 15% of the ...

Read more →

Criticism of study planning: patient-reported endpoints are often collected far too briefly

3 March 2022 - A striking example: abemaciclib in advanced breast cancer. Shortened data on quality of life, symptoms and side ...

Read more →

Patient reported endpoints underrepresented in product information on new drugs

15 December 2021 - An IQWiG team analysed the extent to which patient reported outcomes, which were recorded as endpoints ...

Read more →